findmyKOL

Sanju Varghese, MD

Basic profile

University of Nevada

ORCIDNone on fileNPI
RegionSpringfield, OH · MidwestSpecialtyNephrologyFocusNephrology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2016Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Sanju Varghese is a Nephrology physician affiliated with University of Nevada. OpenAlex indexes 10 publications with 328 citations (h-index 4).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
10publications

Distinct works indexed by OpenAlex.

328citations

Total citations across indexed works.

4h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
36companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

2205 N Limestone St
Springfield, OH 455032675

Telephone

937-322-7521

Provider last certified this registry record 7 Apr 2021.

View the NPPES registry record

Industry payments

36 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    62.9%
    Loop diuretic12.7%
    Furosemide67%Torsemide31%Bumetanide3%
    Part D<11 patients
    Calcium channel blocker7.7%
    Amlodipine Besylate84%Diltiazem 24hr Er (Cd)11%Nifedipine Er5%
    Part D<11 patients

    + 16 more classes in this area

  • Metabolism & gastrointestinal

    18.7%
    SGLT2 inhibitor7.1%
    Farxiga68%Jardiance22%Dapagliflozin11%
    Part D<11 patients
    Potassium supplement6.4%
    Potassium Chloride71%Klor-Con M2018%Klor-Con M1011%
    Part D<11 patients

    + 7 more classes in this area

  • Nervous system

    5.6%
    SSRI4.1%
    Citalopram Hbr92%Escitalopram Oxalate9%
    Part D<11 patients
    Other antidepressants0.9%
    Mirtazapine100%
    Part D11 patients

    + 1 more class in this area

Where care is delivered (Part B)41.4% facility · 58.6% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

5 more publications behind the reveal.Reveal →

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”